Webdisclosure.com

Search

ADC THERAPEUTICS SA EQS-News: ADC Therapeutics Receives Orphan Drug Designation for ADCT-402 for the Treatment of Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma

Directive transparence : information réglementée

09/06/2017 18:24